Aribosan B31 - Liq 3 D Liquid is a Health Canada–registered human drug (DIN 02158876) held by Professional Health Products, containing Quinine Dihydrochloride. Health Canada lists its status as Cancelled Post Market (status date 10 Jul 2006). Nexara Health has matched 15 registrations of Quinine Dihydrochloride across 3 other regulated markets.
Health Canada registration
| DIN | 02158876 |
|---|---|
| Brand name | Aribosan B31 - Liq |
| Active ingredient | Quinine Dihydrochloride |
| Strength | 3 D |
| Dosage form | Liquid |
| Route | Oral |
| Company | Professional Health Products |
| Status | Cancelled Post Market — 10 Jul 2006 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Quinine Dihydrochloride registered in other markets
15 registrations of the same molecule in 3 national registries outside Canada (first 10 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Malta | Quinine hydrochloride S.A.L.F. 500 mg/2 ml concentrate for solution for infusion | Central Procurement & Supplies Unit | Concentrate For Solution For Infusion | Authorised | Medicines Authority | |
| South Africa | Quinine Dihydrochloride Fresenius 300Mg/Ml | Fresenius Kabi Manufacturing SA (Pty) Ltd | 300 mg/ml | Inj | S4 | DoH SEP database |
| United Kingdom | Quinine dihydrochloride 100mg/5ml oral solution | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Quinine dihydrochloride 125mg/5ml oral solution | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Quinine dihydrochloride 150mg/5ml oral solution | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Quinine dihydrochloride 200mg/5ml oral solution | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Quinine dihydrochloride 300mg capsules | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Quinine dihydrochloride 300mg/10ml solution for infusion ampoules | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Quinine dihydrochloride 300mg/1ml solution for infusion ampoules | — | 0001 | NHS dm+d VMP | ||
| United Kingdom | Quinine dihydrochloride 300mg/5ml oral solution | — | 0001 | NHS dm+d VMP |
See every manufacturer of Quinine Dihydrochloride worldwide →
Regulator price references for Quinine Dihydrochloride
Published list or reimbursement prices for Quinine Dihydrochloride presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| South Africa | Quinine Dihydrochloride Fresenius 300Mg/Ml | 300mg/1ml | 1 | 359.67 ZAR | single exit price | DoH SEP database | 2026-09-01 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Aribosan B31 - Liq (DIN 02158876) marketed in Canada?
No. Health Canada lists DIN 02158876 as Cancelled Post Market as of 10 Jul 2006.
Who holds the Canadian licence for this product?
Professional Health Products is the company of record in the Health Canada Drug Product Database.
Is Quinine Dihydrochloride registered outside Canada?
Yes — Nexara Health has matched 15 registrations in 3 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02158876, status date 2006-07-10; national medicine registries: DoH SEP database, Medicines Authority, NHS dm+d VMP; price sources: DoH SEP database. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02158876, status date 2006-07-10; national medicine registries: DoH SEP database, Medicines Authority, NHS dm+d VMP; price sources: DoH SEP database.
Health Canada Drug Product Database (DPD), DIN 02158876, status date 2006-07-10; national medicine registries: DoH SEP database, Medicines Authority, NHS dm+d VMP; price sources: DoH SEP database. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.